Literature DB >> 9557611

Characterization of proteins binding the 3' regulatory region of the IL-3 gene in IL-3-dependent and autocrine-transformed hematopoietic cells.

X Y Wang1, P E Hoyle, J A McCubrey.   

Abstract

Previously we documented the prolongation of the IL-3 mRNA half-life in an autocrine-transformed cell line. This cell line has an intracisternal type A particle transposition in the IL-3 mRNA 3' untranslated region which displaced four out of six AUUUA motifs involved in IL-3 mRNA destabilization. In this study, the proteins binding to the IL-3 mRNA AU-rich elements (ARE) were examined. Specific protein binding was detected to the wild-type IL-3 ARE region which contained 6 AUUUA motifs (AU6). In contrast, no binding was detected to the mutated IL-3 ARE region which contained only two AUUUA motifs (AU2). Proteins with apparent molecular weights of 36, 40, 43, 46, 55, 57, 68 and 95 kDa were bound to AU6 motif. The hnRNP C and AUF-1 (hnRNP D) proteins were determined to be two of the IL-3 ARE binding proteins. Incubation of protein extracts with antibodies to hnRNP C and AUF-1 significantly decreased the protein binding to the IL-3 ARE. Treatment of IL-3 dependent cells with calcium ionophores eliminated the proteins binding to the ARE in wild-type IL-3-dependent FL5.12 cells and also resulted in the accumulation of IL-3 mRNA transcripts with a long half-life. These results indicated that there was a specific complex which bound the IL-3 mRNA 3' ARE. Mutations which truncate the IL-3 ARE eliminate the ability of proteins to bind this regulatory region and can result in autocrine transformation due to the presence of IL-3 mRNA transcripts with a long half-life.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9557611     DOI: 10.1038/sj.leu.2400975

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  7 in total

1.  Differentiation-induced internal translation of c-sis mRNA: analysis of the cis elements and their differentiation-linked binding to the hnRNP C protein.

Authors:  O Sella; G Gerlitz; S Y Le; O Elroy-Stein
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

Review 2.  MRNA stability and the control of gene expression: implications for human disease.

Authors:  Elysia M Hollams; Keith M Giles; Andrew M Thomson; Peter J Leedman
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

Review 3.  The regulation of AβPP expression by RNA-binding proteins.

Authors:  Cara J Westmark; James S Malter
Journal:  Ageing Res Rev       Date:  2012-04-05       Impact factor: 10.895

4.  The internal ribosome entry site-mediated translation of antiapoptotic protein XIAP is modulated by the heterogeneous nuclear ribonucleoproteins C1 and C2.

Authors:  Martin Holcík; Bruce W Gordon; Robert G Korneluk
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

5.  The role of HuR in the post-transcriptional regulation of interleukin-3 in T cells.

Authors:  José A González-Feliciano; Marimar Hernández-Pérez; Luis A Estrella; Daisy D Colón-López; Armando López; Marina Martínez; Kirla R Maurás-Rivera; Clarivel Lasalde; Daviana Martínez; Félix Araujo-Pérez; Carlos I González
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

6.  Inactivation of AUF1 in Myeloid Cells Protects From Allergic Airway and Tumor Infiltration and Impairs the Adenosine-Induced Polarization of Pro-Angiogenic Macrophages.

Authors:  Sofia Gargani; Niki Lourou; Christina Arapatzi; Dimitris Tzanos; Marania Saridaki; Esmeralda Dushku; Margarita Chatzimike; Nikolaos D Sidiropoulos; Margarita Andreadou; Vasileios Ntafis; Pantelis Hatzis; Vassiliki Kostourou; Dimitris L Kontoyiannis
Journal:  Front Immunol       Date:  2022-02-11       Impact factor: 7.561

7.  T cell LFA-1-induced proinflammatory mRNA stabilization is mediated by the p38 pathway kinase MK2 in a process regulated by hnRNPs C, H1 and K.

Authors:  Gautham K Rao; Albert Wong; Mark Collinge; Joseph Sarhan; Timur O Yarovinsky; Vinod S Ramgolam; Matthias Gaestel; Ruggero Pardi; Jeffrey R Bender
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.